{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:14:21Z","timestamp":1791288861684,"version":"4.3.0"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:named-content content-type=\"genus-species\">Pneumocystis jirovecii<\/jats:named-content>\n            pneumonia (PCP) is a common opportunistic infection. Microscopic diagnosis, including diagnosis using the Merifluor-Pneumocystis direct fluorescent antigen (MP-DFA) test, has limitations. Real-time PCR may assist in diagnosis, but no commercially validated real-time PCR assay has been available to date. MycAssay Pneumocystis is a commercial assay that targets the\n            <jats:named-content content-type=\"genus-species\">P. jirovecii<\/jats:named-content>\n            mitochondrial large subunit (analytical detection limit, \u22643.5 copies\/\u03bcl of sample). A multicenter trial recruited 110 subjects: 54 with transplants (40 with lung transplants), 32 with nonmalignant conditions, 13 with leukemia, and 11 with solid tumors; 9 were HIV positive. A total of 110 respiratory samples (92% of which were bronchoalveolar lavage [BAL] specimens) were analyzed by PCR. Performance was characterized relative to investigator-determined clinical diagnosis of PCP (including local diagnostic tests), and PCR results were compared with MP-DFA test results for 83 subjects. Thirteen of 14 subjects with PCP and 9\/96 without PCP (including 5 undergoing BAL surveillance after lung transplantation) had positive PCR results; sensitivity, specificity, and positive and negative predictive values (PPV and NPV, respectively) were 93%, 91%, 59%, and 99%, respectively. Fourteen of 83 subjects for whom PCR and MP-DFA test results were available had PCP; PCR sensitivity, specificity, PPV, and NPV were 93%, 90%, 65%, and 98%, respectively, and MP-DFA test sensitivity, specificity, PPV, and NPV were 93%, 100%, 100%, and 98%. Of the 9 PCR-positive subjects without PCP, 1 later developed PCP. The PCR diagnostic assay compares well with clinical diagnosis using nonmolecular methods. Additional positive results compared with the MP-DFA test may reflect low-level infection or colonization.\n          <\/jats:p>","DOI":"10.1128\/jcm.02390-10","type":"journal-article","created":{"date-parts":[[2011,3,3]],"date-time":"2011-03-03T03:29:54Z","timestamp":1299122994000},"page":"1872-1878","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":88,"title":["Multicenter, Prospective Clinical Evaluation of Respiratory Samples from Subjects at Risk for Pneumocystis jirovecii Infection by Use of a Commercial Real-Time PCR Assay"],"prefix":"10.1128","volume":"49","author":[{"given":"Philippe M.","family":"Hauser","sequence":"first","affiliation":[{"name":"Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Bille","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[{"name":"Department f\u00fcr Hygiene, Mikrobiologie und Sozalmedizin, Medizinische Universit\u00e4t Innsbruck, Innsbruck"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Geltner","sequence":"additional","affiliation":[{"name":"Landeskrankenhaus Natters, Natters, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Feldmesser","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Montefiore Medical Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Montefiore Medical Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Muggia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Montefiore Medical Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Alexander","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hughes","sequence":"additional","affiliation":[{"name":"Myconostica Ltd., Sharston, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Follett","sequence":"additional","affiliation":[{"name":"Myconostica Ltd., Sharston, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Cui","sequence":"additional","affiliation":[{"name":"Myconostica Ltd., Sharston, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Leung","sequence":"additional","affiliation":[{"name":"Myconostica Ltd., Sharston, Manchester, United Kingdom"},{"name":"Present address: Quintiles Hong Kong, Shatin, Hong Kong."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Morgan","sequence":"additional","affiliation":[{"name":"Myconostica Ltd., Sharston, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Moody","sequence":"additional","affiliation":[{"name":"Myconostica Ltd., Sharston, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Perlin","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School\u2014UMDNJ, Newark, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Denning","sequence":"additional","affiliation":[{"name":"Myconostica Ltd., Sharston, Manchester, United Kingdom"},{"name":"The National Aspergillosis Centre, The University of Manchester, Manchester, United Kingdom"},{"name":"Manchester Academic Health Science Centre, Manchester, United Kingdom"},{"name":"University Hospital of South Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.08.006"},{"key":"e_1_3_2_3_2","first-page":"338","article-title":"Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene","volume":"108","author":"Buchman T. G.","year":"1990","unstructured":"BuchmanT. G. RossierM. MerzW. G. CharacheP.. 1990. Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene. Surgery 108:338\u2013347.","journal-title":"Surgery"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/1753465810380102"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.40.4.333.357"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001009"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.088104"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw B.","year":"2008","unstructured":"De PauwB. . 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin. Infect. Dis. 46:1813\u20131821.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsim.2005.06.006"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.2.573"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.45528-0"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540601131976"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200003100-00022"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200602-015MS"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.081687"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3282f94abc"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.2.490-494.2002"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46552-0"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90469-J"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.7.594"},{"key":"e_1_3_2_21_2","unstructured":"Myconostica Ltd. 9 November 2010. Instructions for use for MycAssay Pneumocystis (IVD SmartCycler) version 3.2. Myconostica Ltd. Manchester United Kingdom."},{"key":"e_1_3_2_22_2","unstructured":"NCCLS. 2004. Protocols for determination of limits of detection and limits of quantitation; approved guideline. NCCLS document EP17-A vol. 24 no. 34. NCCLS Wayne PA."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2001.00309.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02091-07"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-004-1200-y"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/588564"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.7.3333-3335.2004"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1010.040453"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.4.830-835.1997"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-008-8027-x"},{"key":"e_1_3_2_31_2","first-page":"478","article-title":"Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection","volume":"41","author":"Su Y. S.","year":"2008","unstructured":"SuY. S. LuJ. J. PerngC. L. ChangF. Y.. 2008. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection. J. Microbiol. Immunol. Infect. 41:478\u2013482.","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1995.tb01110.x"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-45-2-146"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1467"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032588"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-48-10-897"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0396-303"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2005.01337.x"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92008-6"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93062-E"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02390-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02390-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T12:56:30Z","timestamp":1646484990000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.02390-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1128\/JCM.02390-10"],"URL":"https:\/\/doi.org\/10.1128\/jcm.02390-10","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"2010-11-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-02-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-04-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}